Related Articles
Prognosis value of circulating tumor cell PD‑L1 and baseline characteristics in patients with NSCLC treated with immune checkpoint inhibitors plus platinum‑containing drugs
Intrapleural perfusion hyperthermia improves the efficiency of anti‑PD1 antibody‑based therapy for lung adenocarcinoma: A case report
Anti‑PD1 therapy‑associated distal renal tubular acidosis: A case report
PD‑L1 expression is associated with advanced non‑small cell lung cancer
Classification of tumor microenvironment immune types based on immune response-associated gene expression